STEPHEN G. CHARKOUDIAN

Steve Charkoudian is a partner and chair of Goodwin Procter’s Technology Transactions Practice and a member of the firm’s Technology Companies Group. Mr. Charkoudian concentrates on technology and intellectual property transactions, including technology transfers and licensing; collaboration, strategic alliance and joint development agreements; open source issues; and due diligence and other intellectual property issues in mergers, acquisitions and venture capital and private equity transactions. He is a regular contributor to Founder's Workbench and frequently speaks to start-ups and early-stage companies about IP issues.

 

WORK FOR CLIENTS

Mr. Charkoudian’s representative transactions include:

• WiTricity, Inc. in an agreement with Delphi Automotive to develop automatic wireless charging products for hybrid and electric vehicles. The collaboration between the two companies will help establish a global infrastructure of safe and convenient charging options for consumer and commercial electric vehicles. WiTricity Corporation designs, develops, manufactures and markets patented technology for wireless energy transfer.
• Citrix Systems, Inc., with respect to a collaboration agreement with Microsoft to support the Microsoft RemoteFX technology platform.
• Haemonetics Corporation, in connection with a significant evaluation, supply and license agreement with Quotient Biodiagnostics Group and its wholly owned subsidiary Alba Bioscience Limited. The agreement provides Haemonetics with exclusive access to Alba's comprehensive catalogue of approved reagents for use in the Arryx laser-based blood typing platform.
• MTV Networks, a division of Viacom, with respect to intellectual property and technology matters in its acquisition of Harmonix Music Systems, developer of the hits Guitar Hero, Rock Band and other music gaming titles.
• Inverness Medical Innovations Inc., with respect to intellectual property and technology matters in connection with a 50/50 joint venture with The Procter & Gamble Company for existing and to-be-developed consumer diagnostic products.
• Inverness Medical Innovations Inc., in intellectual property and technology matters related to its acquisition of ACON Laboratories Inc.’s manufacturing facility in Hangzhou, China and its lateral flow immunoassay business in the United States, Canada, Western Europe, Israel, Australia, Japan and New Zealand.
• Haemonetics Corporation, in connection with a collaboration and license agreement with Arryx, Inc. under which Haemonetics was licensed to use Arryx’s optical trapping technology to develop applications for human healthcare applications. Represented Haemonetics in its later acquisition of Arryx.
• Vicor Corporation, in connection with a license to Sony Corporation that allows Sony to design and manufacture power converters, using Vicor’s V-I Chip technology and Factorized Power Architecture, for use and sale as part of Sony’s products.
• Bessemer Venture Partners, in connection with its investment in OMGPOP, the online place where people meet each other to play games.
• Turbine, Inc., with respect to its distribution and localization agreement with CDC Games, a wholly owned subsidiary of China.com Inc., a business unit of CDC Corporation, for The Lord of the Rings Online™: Shadows of Angmar™.
• CCP Games (maker of the MMOG EVE Online) in intellectual property and technology matters, in connection with its merger with White Wolf Publishing, the world’s second-largest developer of offline role-playing, strategy and collectable card games.
• TA Associates, regarding intellectual property and technology matters in its investment in Mythic Entertainment, the developer of MMORPG Dark Age of Camelot.

PROFESSIONAL ACTIVITIES

Mr. Charkoudian is a member of the Boston and Massachusetts Bar Associations and the International Technology Law Association. He has been selected for inclusion in Chambers USA: America’s Leading Lawyers for Business and has been recognized as a “Leading Licensing and Technology Transactions Lawyer” by Intellectual Asset Management magazine as part of its IAM Strategy 300 survey.

BAR AND COURT ADMISSIONS

Mr. Charkoudian is admitted to practice in Massachusetts.